Skip to main content

Severe Coxsackie virus B infection in preterm newborns treated with pleconaril

Abstract

Four preterm newborn infants with severe multisystem Coxsackie virus B infection were treated with an oral suspension of pleconaril (5 mg/kg per day). The patients had myocarditis, fulminant hepatitis, meningoencephalitis and disseminated intravascular coagulopathy. All four infants recovered, and no adverse effects of the treatment were noted. Conclusion: pleconaril needs to be comprehensively evaluated in this population.

This is a preview of subscription content, access via your institution.

Author information

Affiliations

Authors

Additional information

Electronic Publication

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bauer, S., Gottesman, G., Sirota, L. et al. Severe Coxsackie virus B infection in preterm newborns treated with pleconaril. Eur J Pediatr 161, 491–493 (2002). https://doi.org/10.1007/s00431-002-0929-5

Download citation

  • Coxsackie virus Enterovirus Neonate Pleconaril